Jakap Koo, Director of Apimeds Pharmaceuticals US APUS, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/11/11.

JK

JK

Jakap Koo

Director

Company

Apimeds Pharmaceuticals US APUS

First filing

25/05/14

Trades

4 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

25/11/11

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Apimeds Pharmaceuticals USAPUS	Open-market buy	25/05/12	25/05/14	28,500 sh	$1.99	$56,715	+4.6%